Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $334.47 firm fixed price delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication, for performance at its Conshohocken, Pennsylvania facility from July 21-24, 2023. The award is issued against the DLA's pharmaceutical prime vendor contract vehicle to support the medical readiness of DOD personnel. No subcontractors...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $533 delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The firm fixed price contract was issued utilizing the DLA's Pharmaceutical Prime Vendor program, which centrally manages pharmaceuticals for the Department of Defense and other...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone treatment, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and provisioning medical...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,443.02 from the Defense Logistics Agency (DLA) to supply 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 2, 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with DLA Troop Support Medical to provide pharmaceuticals and...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $860 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a testosterone replacement drug. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 30th to August 31st, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, responsible for...
Amerisourcebergen Drug Corp has been awarded a $1,002.12 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical contract vehicle to supply 50 MG/0.5 ML auto-injectors of XYOSTED, a medication for testosterone replacement therapy. Performance will occur in Conshohocken, Pennsylvania by October 2023. The Defense Logistics Agency supports military readiness by procuring and providing medical supplies and pharmaceuticals to the Department of Defense. No...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $502.86 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will take place in Conshohocken, Pennsylvania under a one-day period from July 10-11, 2023. No subcontractors or set aside designations were indicated. This order is likely placed against DLA's...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on August 29, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
The Defense Logistics Agency awarded a $6,165.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. The place of performance will be in Conshohocken, Pennsylvania over the period of August 1-2, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling this order to supply the injectable testosterone cypionate product in support of DLA programs. No major...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,508.58 delivery order contract by the Defense Logistics Agency to supply XYOSTED, a testosterone replacement therapy medication. Performance will take place in Conshohocken, Pennsylvania over a one day period from July 26-27, 2023. The firm fixed price contract was awarded under the DLA's pharmaceuticals and medical/surgical supply vehicle. No subcontractors or set aside designations were...